Lieke L. van der Woude

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

Steve Boudewijns, Martine Bloemendal, Nienke de Haas et al. · Cancer Immunology Immunotherapy · 2020 · 58 citations · Full text

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination

Lieke L. van der Woude, Mark A.J. Gorris, Inge M. N. Wortel et al. · Journal for ImmunoTherapy of Cancer · 2022 · 36 citations · Full text

Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome

Mark A.J. Gorris, Lieke L. van der Woude, Leonie I. Kroeze et al. · Journal for ImmunoTherapy of Cancer · 2022 · 24 citations · Full text

Ipilimumab-treated Melanoma, Cancer Immunosurveillance, Medicine +14

ImmuNet: A Segmentation-Free Machine Learning Pipeline for Immune Landscape Phenotyping in Tumors by Muliplex Imaging

Shabaz Sultan, Mark A.J. Gorris, Evgenia Martynova et al. · 2021 · 16 citations · Full text

Engineering, Digital Pathology, Immunology +22

Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype

Sandra van Wilpe, Donjetë Simnica, Peter H. J. Slootbeek et al. · OncoImmunology · 2022 · 11 citations · Full text